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Abstract—Transcriptional profiling on microarrays to obtain
gene expressions has been used to facilitate cancer diagnosis. We
propose a deep generative machine learning architecture (called
DeepCancer) that learn features from unlabeled microarray data.
These models have been used in conjunction with conventional
classifiers that perform classification of the tissue samples as
either being cancerous or non-cancerous. The proposed model
has been tested on two different clinical datasets. The evaluation
demonstrates that DeepCancer model achieves a very high
precision score, while significantly controlling the false positive
and false negative scores.
Index Terms—gene expressions, deep generative learning, con-
volution, supervised classification
I. INTRODUCTION
Detection of cancer has always been at the forefront of
all research endeavors within the medical community. Ad-
vancements in medical sciences and technology have given
birth to numerous methodologies that leverage the availability
of massive amounts of data to provide valuable insight into
several cancer-related processes [1], despite the complexity
associated with these methodologies. Gene expression profil-
ing technologies comprise one such research avenue that relies
on establishing correlations between different gene-expression
data, which are generated through oligonucleotide arrays or
cDNA microarrays, and the different cell stages observed in
cancer patients, thus enriching cancer taxonomy [2] [3]. Owing
to this ability, this technology has been widely applied to
study and enhance diagnosis of breast cancer and prostate
cancer. Inflammatory breast cancer literature [4] reports that
1-5% of all cancer-based mortalities in the United States in
2011 were due to the highly rare inflammatory breast cancer
which is known to be exhaustively difficult to diagnose, while
prostate cancer has been predicted to occur in about one-
quarter of all male cancer diagnoses[5], thereby impressing
an urgent need for more reliable diagnosis techniques. Current
literature is rife with instances of thorough research of gene
signatures in attempting to distinguish genes expressed in
affected (cancerous) tissues from those expressed in normal
(non-cancerous) tissues, yet high data dimensionality is an in-
herent characteristic of these microarray experiments, thereby
persistently posing a serious challenge to reliable and effective
diagnosis.
There are several machine learning models that address this
challenge. Since these models learn from experience, reliable
classification demands extensive training on data that are
usually heterogeneous in that real-world data samples belong
to disparate classes with a high likelihood of redundancy in
data, thus resulting in high dimensionality. Therefore, these
models have been designed and/or improved to tackle the
curse of dimensionality [6] in a way that they are suitable for
scenarios involving high dimensions. Deep machine learning
[7], a specialized subset of machine learning, presents a class
of data-friendly models that are highly efficient in learning
hidden features intrinsic to the data based on a multilayered
architecture, with lower layers learning simpler features and
eventually composing them into more complex ones in subse-
quent layers in either a supervised or an unsupervised fashion.
DeepCancer explores one such model called Generative Ad-
versarial Networks [8] that involve a generative network and an
inference network functioning in an adversarial learning setup.
The generative network learns to probabilistically generate
output samples, given random noise as input, whereas the
inference or discriminator network learns to discriminate the
true data distribution samples from the generated fake data
distribution samples. This way, the generator tries to fool the
discriminator by trying to generate progressively better fake
samples, and the discriminator tries best not to be fooled by
the generator by improving its ability to classify samples as
either being real or fake, until the generated samples are indis-
tinguishable from the original samples. These features learnt
by the discriminator from gene expression microarray data can
finally be passed through sigmoid activation for supervised
classification of gene samples as either being cancerous or
non-cancerous. We test the ability of our model in classifying
breast cancer and prostate cancer samples and show that this
hybrid model performs this classification task accurately. Also,
as a baseline, we implement a standard Restricted Boltzmann
Machine (RBM) [9] that works, similar to these adversarial
networks, in a pipeline with a traditional classifier.
II. RELATED WORK
Gene expressions have classically been researched quite
extensively through employing machine learning (ML) tech-
niques in the context of both supervised and unsuper-
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vised methods of training. Unsupervised clustering, includ-
ing its variants such as hierarchical or k-means cluster-
ing [10] [11] [12] [13], have been widely used methods to
analyze gene expression data [14] [15] [16] [17] [18] [19].
Clustering based on metrics like correlation coefficients was
explored in [20] in order to represent relationships among
genes in a tree structure with the branch length signifying the
degree of mutual similarity computed by a pairwise average-
linkage cluster analysis similarity function. Affinity propaga-
tion clustering algorithm, apart from spectral clustering, has
been explored in [21] wherein a pairwise similarity matrix is
the input to the algorithm when the number of clusters is un-
known. Multivariate Gaussian mixture models have also been
used as the fundamental principle to perform unsupervised
clustering of breast cancer samples [22], to perform supervised
clustering analysis of gene expressions of yeast cell data [23].
Additionally, Euclidean distance has also been utilized as a
metric for performing gene clustering [10].
On the other hand, historically, artificial neural networks
(ANNs) have been employed in a supervised framework
to analyze gene-expression signatures of small, round blue
cell tumors generated by cDNA microarrays and perform
diagnostic classification [24]. ANNs have also been applied
in esophageal cancer research in order to analyze cDNA
microarray data [25], to distinguish renal cell carcinomas
from normal renal cysts [26], and also in the prediction of
colorectal cancer [27]. Another variant of ANNs called self-
organizing maps (SOMs) [28] [29] have been equally exploited
for carrying out clustering of gene signatures [30] [18],
although in an unsupervised manner. At the heart of this
algorithm is the concept of centroid-based clustering [31],
i.e., the algorithm creates as many centroids as defined by
the user by using the data points yielding an optimal set
of centroids, which leads to multiple clusters consisting of
these ‘nearby’ data points. Support vector machines (SVMs)
have been employed because of their ability to choose sparse
solutions in high multidimensional feature spaces while re-
jecting outliers in functionally classifying gene expression data
from DNA microarray hybridization experiments [1] [32] [33].
The fundamental notion involves a margin maximization that
effectively separates samples belonging to different classes
while respecting generalization to perform highly reliable
classification of new (unseen) samples.
In this paper, we present an adversarial model that genera-
tively learns features from the true data distribution, thereby
improving the discriminator’s classification efficiency. This
discriminator’s features are passed through sigmoid activations
prior to classifying a sample as either being cancerous or
‘normal’. Also, to realize the efficacy of this adversarial
network, we propose two models as baseline: an RBM that
is trained in a pipeline with a traditional Logistic classifier
and another with the SVM.
Fig. 1. A Restricted Boltzmann Machine Markov network [34]
III. GENERATIVE LEARNING MODELS
A. Restricted Boltzmann Machines
Restricted Boltzmann Machines (RBMs) are structured
probabilistic, energy-based, generative, undirected graphical
models that learn probability distributions over the set of
the provided inputs. As shown in Fig. 1, these networks
typically consist of binary multiple visible layers and a single
latent or ‘hidden’ layer, and are characterized by a bipartite
graph design, i.e., direct interactions between any variables in
the visible layer or between hidden units is restricted, thus
justifying its nomenclature [35] [34]. These layers can be
stacked one on top of the other for designing deeper models.
This model involves determining the ‘energy’ or the joint
probability distribution of a pair of a visible and hidden unit
(v and h respectively) as per the energy function [34] given
by:
P (v, h) =
1
Z
exp{−E(v, h)} (1)
where b, c, and W are unconstrained, real-valued, learnable
parameters and Z is the normalizing constant known as the
partition function:
Z =
∑
v
∑
h
exp{−E(v, h)} (2)
Also, the energy function of an RBM, E(v, h), parameterizes
the relationship between the visible and hidden variables:
E(v, h) = −bT v − cTh− vTWh (3)
This translates directly to the following free energy formula:
F (v) = −b′v −
∑
i
log
∑
hi
ehi(ci+Wiv) (4)
Furthermore, the gradient of the log probability of a training
vector with respect to these weights comes from Eq. ??
∂logP (v)
∂wij
= 〈vihj〉data − 〈vihj〉model (5)
where the angle brackets denote expectation under the distri-
bution specified by the accompanying subscript. Since, there
are no direct connections between the hidden units and within
the visible units, we get unbiased samples of 〈vihj〉data, for
hidden and visible units respectively, according to:
P (hi = 1|v) = σ(
∑
j
wijvi + cj) (6)
P (vi = 1|h) = σ(
∑
j
wijhj + bi) (7)
The two terms in Eq. ?? are referred to as the positive and the
negative phase, where the terms ’positive’ and ‘negative’ refer
not to the signs but their effect on the probability density of the
model. The first term increases the probability of the training
data (by reducing the free energy), whereas the second term
has the opposite effect. However, the term 〈vihj〉model is more
intractable. Therefore, a standard practice is to numerically
approximate by drawing samples from the data distribution.
Then, a reconstruction is done in three simple steps:
1) Assign training vector to visible units
2) Compute hidden unit states using Eq. ??
3) Compute reconstruction by setting each vi to 1 with
probability given in Eq. ??.
The resultant change in weights is similar to Eq. ??:
∆wij = (〈vihj〉data − 〈vihj〉recon) (8)
where  is the learning rate. This technique is called Con-
trastive Divergence and its approximation is a difference
mathematically written as:
CDn = KL(p0||p∞)−KL(pn||p∞) (9)
where, KL(.) is the Kullback-Liebler divergence for the model
p∞ and for the data p0.
B. Generative Adversarial Networks
A fairly recent and far less researched model, generative
adversarial networks [8] (GANs) in the context of deep ma-
chine learning are generative models involving two networks
competing against each other – a generator that tries to mimic
examples from the training dataset, which is sampled from the
true data distribution. The discriminator receives samples from
the without being told where the sample came from. Therefore,
it tries to predict whether a sample is ‘true’ or synthetic. This
way, the discriminator tries to classify samples as accurately
as possible, while the generator tries to fool the discriminator
into thinking the sample came from the true data. This two-
player minmax game, thereby, improves the ability of both
the networks to perform their task as accurately as they can,
until the ‘fake’ samples are virtually indistinguishable from
the original samples.
Mathematically, as explained in [8], a prior on input noise
variables pz(z) is defined to learn the generator’s distribution
pg over data x. This prior is then used to represent a mapping
to the data space as G(z; θg) , where G is a differentiable
function represented by a multilayer perceptron. Similarly,
D(x, θd) represents the probability of x belonging to the true
data distribution. Therefore, the minmax game of the model
defines a loss function:
min
G
max
D
V (D,G) = Ex∼pdata(x)[logD(x)]
+Ez∼pz(z)[log(1−D(G(z)))]
(10)
where, D is maximized to assign the correct label to both
the true and the generated samples, and G is trained to
minimize the logarithm term, log(1 − D(G(z))) . This is
achieved through k stochastic gradient ascent update steps on
the discriminator as:
5θd
1
m
m∑
i=1
[logD(x(i)) + log(1−D(G(z(i))))] (11)
The generator updates through only one step of stochastic
gradient descent:
5θg
1
m
m∑
i=1
log(1−D(G(z(i)))) (12)
Ideally, after several updates epochs, for a fixed G, at optimal-
ity,
D∗G(x) =
pdata(x)
pdata(x) + pg(x)
(13)
where D∗ denotes the optimal discriminator.
C. Deep Convolutional GAN
The DeepCancer architecture comprises a deep convolu-
tional GAN inspired by the model in [36]. This is based on
LeCun’s model [37], which is most often employed in the
supervised learning literature. As explained in Algorithm 1,
we initially accept a 100-dimensional noise vector as the input
to the generator. This is reshaped, batch-normalized and up-
sampled to a small spatial extent convolutional representation
that goes through multiple convolutions with many activation
maps. Finally, the high-level representation converts the input
to a 224x183 dimensional map. On the other hand, this map
acts as the input to the discriminator, which progressively
convolves over the activation maps. These maps are flattened
at the fully connected layer and passed through a sigmoid
activation in order to carry out binary classification of samples.
For our generator model, batch normalization was employed
for the model to learn features from samples passed in batches.
Rectified Linear Units (ReLU) activations [38] were used.
For our discriminator model, we employed LeakyReLU [39]
activations and a dropout rate of 0.50.
A fundamental reason why DeepCancer is based on deep
convolution networks is because of their excellent ability to
learn features over different regions of the incoming input,
while reducing the number of free parameters, which may
invariably increase drastically in case of deep architectures.
While our dataset doesn’t explicitly demand deep architec-
tures (networks with far more convolutional layers) like in
’ResNet’ [40], our adversarial model presents the scope for
excellent results even in the case of larger datasets that will
ultimately involve much more free parameters.
Furthermore, convolution networks involve the neurons
looking only at the convolving local receptive areas, and hence
learning different features from different portions of the weight
matrices, thereby strengthening the generalization ability of the
model.
Fig. 2. Fig. 2 Deep Convolutional architecture for the adversarial network. The dimensions shown are for the GEO ID GSE45584 dataset. The corresponding
parameters for the prostate cancer task are mentioned in Table III
Algorithm 1 Deep Convolutional Model for adversarial training. The generator–discriminator pair learns features through
convolutions over input matrix. k is a hyperparameter for the discriminator. k = 1 proved to be sufficient.
for number of epochs do
for k steps do
Sample minibatch of noise examples from the standard uniform distribution
Sample minibatch of examples from the data distribution
Perform convolutions on the input
Flatten the convolution ouput and pass through sigmoid
Compute gradients through the optimization function
Freeze the discriminator traning
end for
Sample minibatch of noise examples from the standard uniform distribution
Reshape and upsample the minibatch for convolutions
Perform 2-dimensional convolutions on the minibatch
Execute stochastic gradient descent on G
end for
IV. EVALUATION
Two datasets have been utilized for testing DeepCancer. To
introduce some terminology, ‘Alpha’ refers to the learning
rate, ‘Logistic C’ refers to the regularizer of the Logistic
Regression model, ‘svm C’, refer to the cost regularizer of
the SVM, ‘gamma’ refers to the penalty constant of the SVM,
‘NoC’ refers to the number of components, i.e., hidden units
of the RBM. Also, in the GAN models, ‘AlphaD’ and AlphaG
refer to the learning rates of the discriminator and the generator
respectively.
A. Datasets
1) GSE45584 Breast Cancer Dataset: The dataset used
for evaluating the model’s ability to classify inflammatory
breast cancer (IBC) samples is the accession ID GSE45584
dataset, which was created in [41] and is currently part of the
Gene Expression Omnibus data repository that houses curated
microarray gene expression profiles for research purposes. The
45 samples (20 IBC, 20 non-IBC and 5 normal tissues) and
their corresponding accession IDs are tabulated in Table I.
For each of these samples, we have 41000 unique genes
whose expression levels are positive floating-point real values
that collectively indicate the activity, i.e., the expression of
these several thousand genes in cellular function. Since genes
contain instructions for messenger RNA (mRNAs), the extent
of their contributions can be treated as the gene either being
on or off while producing that mRNA. Furthermore, since nu-
merous external factors decide whether or not a gene produces
an mRNA, these expression profiles help in understanding
the cell state, type, or environment among other attributes.
Deep generative learning models understand these expressions,
probabilistically firing neurons as per the expression level
based on the aforementioned deep architecture that is capable
of tackling high data dimensionality with minimal feature
engineering, unlike traditional machine learning or hierarchical
clustering approaches that depend on statistical tests to extract
the most important features before performing classification.
A key aspect of the paper is the size of this dataset.
Inflammatory breast cancer is rare [4] and is characterized by
the rapid onset of the erythema and swelling of the breast
without any obvious breast mass. Therefore, owing to this
characteristic of inflammation, diagnosis becomes extremely
tedious, making retrieval of IBC samples difficult to obtain.
Hence, the dataset compares gene expression levels of only
twenty microdissected IBC samples with twenty microdis-
sected non-IBC samples based on the marker status on the
Human Epidermal Growth Factor Receptor (HER2/neu) am-
plification, and the Estrogen Receptor (ER) [41], apart from
including five non-cancerous samples.
2) Prostate Cancer Dataset: The other dataset used in
this paper is the prostate cancer dataset used in [42], which
involves fifty-two cancerous and fifty non-cancerous prostate
specimens. In this case, for each sample, expressions of
12600 unique genes collectively indicated the gene activity.
An important difference is that, unlike the GEO ID GSE45584
dataset, the expression levels were floating-point positive and
negative real values. The central idea here is the same -
profiling the expression levels indicate cellular activity and
attributes like state. A similar procedure that was applied to
the first dataset was also applied to the second dataset, with
the evaluation metrics recorded being the same. Similar to the
first dataset, the model segregated the samples into two classes
cancerous and non-cancerous prostate samples.
B. Training
The RBM-based models for the breast cancer dataset were
tested on two different types of tasks:
• Task 1: Classification of breast cancer tissues as either
being non-inflammatory or inflammatory
• Task 2: Classification of tissues as either being cancerous
and non-cancerous
whereas the prostate cancer classification involved only one
task: classification of tissues as either being cancerous and
non-cancerous.
To accommodate for the first task, the five non-cancerous
samples were removed during the preprocessing stages in order
to ensure that only tissues diagnosed as cancerous were used
by all the models. For the second task, the five normal breast
tissues were augmented 8 times to ensure dataset balancing
and prevent model training bias. These augmented samples
formed the non-cancerous class, and were then concatenated
with all the 20 non-IBC and 20 IBC samples that were grouped
together to yield the cancerous class. Therefore, for the first
task, the size of the input matrix after preprocessing was 40 X
40992, accommodating 20 samples each of the IBC and non-
IBC categories, whereas for the second task, this size after
dataset augmentation was 80 X 40992. The original prostate
cancer dataset has two separate files as training and test data,
with 25 prostate samples and only 9 non-prostate samples in
the test data, both these files were combined to obtain an input
matrix of size 136 X 12600. Prior to training, samples were
shuffled and then split into training and testing sets to avoid
any model bias or overfitting.
Similarly, for DeepCancer, we recognized three different
tasks:
• Task 1: Classification of breast cancer tissues as either
being cancerous and non-cancerous.
• Task 2: Classification of breast cancer tissues as either
being inflammatory or non-inflammatory.
• Task 3: Classification of prostate cancer tissues as either
being cancerous and non-cancerous.
Similar to the RBM-based models, to carry out these GAN-
based tasks, three tasks were defined as tabulated in Table II.
Size of the input matrices for DeepCancer model was similar
to that used in the ID GSE45584 dataset. Different training
and test split proportions were tested, as mentioned in the
subsequent sections below.
A key aspect of the paper is the size of the ID GSE45584
dataset. Inflammatory breast cancer is quite a rare form of
cancer [4] and extremely tedious to diagnose, making retrieval
of inflammatory breast cancer samples difficult to obtain.
Therefore, while the paper focusses on a smaller dataset, the
authors believe that the model should perform equally well for
bigger datasets.
Table III represent the architecture design of our GAN
model; the GSE45584 and the prostate cancer dataset hyper-
parameters are separated by ‘/’.
TABLE III
CONVOLUTIONAL GAN ARCHITECTURE PARAMETERS
Layer Kernel length/ Number of Kernel/
Pool Size* Number of Neurons*
Generator Module
Dense1 - 40992*/12600*
UpSampling1 (32,3)*/(10,10)*
Convolution2 3/3 48/50
Convolution3 3/3 32/25
Convolution4 1/1 1/1
Discriminator Module
Convolution5 3/3 32/32
Convolution6 3/3 64/64
Dense2 - 64*/64*
Dense3 - 2*/2*
C. Evaluation Metrics
Since the nature of the task is human-centric, i.e., to classify
breast cancer tissues based on gene signatures, the most
appropriate metric that preserves this nature is the precision-
recall metric. Therefore, conforming to statistical postulates, a
high precision and high recall imply that the model is able to
correctly classify all the detected samples. A high precision
with low recall implies that the model detects fewer samples
but classifies almost all of them correctly. Whereas, lower
precision with higher recall implies that the samples are being
misclassified. This is particularly important to understand
since, pertaining to the nature of the task, a non-inflammatory
breast cancer sample classified as an inflammatory sample
is medically inaccurate but ultimately tolerable as compared
to the highly undesirable scenario of inflammatory samples
classified as non-inflammatory, given that inflammation poses
far more serious medical consequences.
TABLE IV
LEARNING RATE OF THE RBM-SVM MODEL EXAMINED ON THE
GSE45584 DATASET WITH THE NOC = 200, SPLIT=0.5, SVM C=1,
EPOCHS=50, GAMMA=0.06
Alpha Precision Recall F1-Score
0.0006 79 65 60
0.0009 83 75 74
0.001 71 70 71
0.005 86 80 79
0.01 78 60 52
TABLE I
ACCESSION IDS OF THE 20 IBC, 20 NON-IBC AND 5 NON-CANCEROUS SAMPLES FROM THE RAW GSE45584 DATASET
Serial No. Non-IBC IBC Non-Cancerous
Sample Geo accession ID Sample Geo accession ID Sample Geo accession ID
1 LGt008 GSM1110043 MB001 GSM1110063 LGp02NT GSM1110083
2 LGt010 GSM1110044 MB002 GSM1110064 LGp03NT GSM1110084
3 LGt024 GSM1110045 MB003 GSM1110065 LGp05NT GSM1110085
4 LGt025 GSM1110046 MB004 GSM1110066 LGp07NT GSM1110086
5 LGt032 GSM1110047 MB005 GSM1110067 LGp09NT GSM1110087
6 LGt033 GSM1110048 MB006 GSM1110068
7 LGt038 GSM1110049 MB008 GSM1110069
8 LGt052 GSM1110050 MB009 GSM1110070
9 LGt058 GSM1110051 MB010 GSM1110071
10 LGt066 GSM1110052 MB014 GSM1110072
11 LGt067 GSM1110053 MB016 GSM1110073
12 LGt075 GSM1110054 MB018 GSM1110074
13 LGt082 GSM1110055 MB022 GSM1110075
14 LGt099 GSM1110056 MB025 GSM1110076
15 LGt107 GSM1110057 MB026 GSM1110077
16 LGt126 GSM1110058 MB028 GSM1110078
17 LGt131 GSM1110059 MB029 GSM1110079
18 LGt134 GSM1110060 MB030 GSM1110080
19 LGt137 GSM1110061 MB031 GSM1110081
20 LGt141 GSM1110062 MB032 GSM1110082
TABLE II
THREE DIFFERENT TASKS WITH SUB-TASKS DEFINED FOR EVALUATION OF THE CONVOLUTIONAL GAN MODEL
Task Part-I Part-II
a b a b
Task1 Tr:Cancerous, Ts:Cancerous Tr:Cancerous,Ts:Non-Cancerous Tr:Non-Cancerous,Ts:Non-Cancerous Tr:Non-Cancerous, Ts:Cancerous
Task2 Tr:IBC,Ts:IBC Tr:IBC, Ts:Non-IBC Tr:Non-IBC,Ts:Non-IBC Tr:Non-IBC,Ts:IBC
Task3 Tr:Prostate,Ts:Prostate Tr:Prostate, Ts:Non-Prostate Tr:Non-Prostate,Ts:Non-Prostate Tr:Non-Prostate,Ts:Prostate
Fig. 3. Variations in evaluation scores due to gamma on the GSE45584 dataset
for the RBM-SVM model
Fig. 4. Variations in evaluation scores due to regularizer C on the GSE45584
dataset for the RBM-Logistic model
D. Model Performance
In order to appropriately test the efficacy of the system
in the presence of different hyperparameters, only one of
TABLE V
GAMMA OF THE RBM-SVM MODEL EXAMINED ON THE GSE45584
DATASET WITH NOC = 200, SPLIT=0.5, SVM C=1, EPOCHS=50,
ALPHA=0.0006.
Gamma Precision Recall F1-Score
0.0003 34 40 34
0.001 79 65 60
0.008 81 70 67
0.06 79 65 60
1.5 78 60 52
them was varied while all the others were fixed. These fixed
hyperparameters were recorded after multiple rounds of model
selection and the set of values that yielded the most optimal
results have been used.
Based on the aforementioned implementation, training and
evaluation procedures, the baseline RBM-Logistic Regression
model on the GSE45584 dataset, was able to detect 20
samples: 12 non-IBC and 8 IBC. Its performance, as shown in
Fig. 5(a), was significantly favorable for differentiating non-
IBC samples from IBC samples with 88% (approximately 11
out of 12 samples) model average precision score, with an
associated average recall score of 85%, thereby indicating that
the model learns to classify an IBC tissue accurately.
Also, the learning rate hyperparameter of the RBM is
a key component that governs how effectively convergence
occurs in the model. The best precision score was observed
for a learning rate of 0.001 with the precision-recall curve
eventually dropping sharply below 0.001, further suggesting
the condition of optimality in feature learning. Another key
hyperparameter is the model pipeline is logistic regularizer, C,
that is traditionally used to avoid ’underfitting’ (model bias)
by learning many features. Basically, some features may be
assigned higher weights than others, thus biasing the model
and reducing precision. To avoid this, features with extremely
high weights are rejected while ensuring effective learning and
smooth convergence to local minima. Therefore, balancing
this trade-off between effective feature learning and higher
precision is crucial to our task, since lesser learning may
impact the overall performance of the system. As Fig. 4
shows, the most optimal C was experimentally found to be
1.8 for an average precision of 77% (approximately 10 out
13 samples). Interestingly, the corresponding recall score of
54% once again validates the efficacy of our model in terms
of accurate classification to a good extent.
The RBM-SVM model (Tables IV and V) detected 10 IBC
and 10 non-IBC samples and performed equally well, reporting
86% (approximately 9 out 10 samples) as the highest average
precision score with the recall score being 80% implying
accurate classification of almost all the detected IBC samples.
The learning rate of the RBM was most optimal for 0.005
with the steepest drop in precision thereafter. Likewise, the
penalty term, γ led to significant increase in model precision
after much experimentation. While, γ = 0.0003 reported a
precision of just 34%, fine-tuning it to the range 0.001–0.06
presented a much higher precision range. Also, recall scores
recorded for variations in γ led to higher recall. Overall, the
model was able to pick up highly relevant features and classify
almost all the detected samples accurately.
On the second task, the RBM-Logistic model yielded an
average precision of 89% (approximately 17 out of 18 IBC)
samples for α = 0.05 (Fig. 5(e)), while reporting an equally
high recall of 85%. Furthermore, tweaking to α = 0.03
resulted in all detected IBC samples being accurately clas-
sified. Other parameters such as train-test data split was also
experimentally tested to record observations. 40–60% of the
dataset assigned as the test set proved to be most effective for
learning.
Similarly, for the prostate cancer dataset, the RBM-Logistic
Regression model performed very well with increased number
of hidden neurons performing exceedingly well in differenti-
ating the cancerous samples from the non-cancerous samples
(Fig. 6(a)). A direct relationship between the number of
hidden units and model precision is discernible, as the average
precision increased steadily from 69% using 300 neurons to
91% using 1000 neurons. Compared to the SVM classifier in
task 1, the model learnt to classify far better using α = 0.0005.
Interestingly, the average precision improves after α = 0.01
but this was observed keeping NoC = 600. This may not be
the case if the NoC were higher.
The performance of DeepCancer was far better than the
baseline model, with the generator learning to accurately rep-
resent the features of the GSE45584 dataset and imitating the
characteristics well enough to be discriminated favorably by
the discriminator, i.e., the discriminator accepts these samples
after several epochs of discrimination between real and fake
samples, thereby improving in its ability to classify samples
into their appropriate categories.
A general practice in computationally-heavy models is to
pre-train the networks in order to reduce the overall compu-
tation time. However, due to a dataset relatively smaller than
popular datasets such as the MNIST [37], pre-training was
observed to be an essential but avoidable step. We exhaustively
experimented with the learning rate of the discriminator and
examined the effect of epochs on precision-recall and reported
this performance (Fig. 7). On Task 1, the learning rate of
the discriminator for the range α = 0.00001 to α = 0.001
(Fig. 7(b)). Very clearly, as the learning rate was increased,
the precision-recall pair of the model starts to decrease in 10
percentage-points, and finally misclassifies half of the samples
for the highest value of α = 0.001. This is in line with machine
learning theory, since greater the learning rate of the model, the
more difficult it is for the model to achieve convergence while
updating the gradient descent parameters. Additionally, F1-
Scores are a good indicative of the general overall performance
of the model, since it considers the harmonic mean of the
precision and recall scores. On Task 1, our model reports
an overall average F1-Score of 84%, indicating a favorable
performance against the objective of two-class classification.
Similarly, for Task 2, Fig. 7(d) shows that as the learning
Fig. 5. Effects of different configurations of the model on the Average Precision, Recall and F1-scores
rate was increased, the performance of the model deterio-
rates with the model going from classifying accurately at
α = 0.00003 to misclassifying half the samples at α = 0.001.
An interesting phenomenon that we repeatedly observed was
a sudden spike in the precision for α = 0.0003. This, the
authors believe, was probably because of the gradient getting
stuck in local minima during gradient descent, a persistent
problem in machine learning while descending quickly. For
these observations, the F1-scores falls drastically from 100%
to about 67% as the algorithm undergoes gradient descent.
Also, the precision-recall scores obtained for Task 2 part 2(b)
were expected to be far apart, considering the nature of the
task: to classify non-IBC from IBC samples after training on
non-IBC samples and testing on IBC samples (Table VI).
TABLE VI
EFFECTS OF VARYING THE LEARNING RATE OF THE DISCRIMINATOR
IN TASK 2 PART 2(B)
AlphaD Precision Recall F1-Score
0.00003 55 100 70
0.0001 50 100 67
0.0003 30 95 45
0.001 25 100 40
GAN models are inherently difficult to train [36] and require
number of epochs for generation-based tasks. To test this,
the number of training and testing epochs was experimentally
modified to study its impact. On Task 3 part 1(a), 2 epochs led
to a precision of just 79% (Fig. 7(f)), and a steady increase
in accuracy was observed as the epochs were increased to 8.
TABLE VII
EFFECTS OF VARYING THE LEARNING RATE OF THE DISCRIMINATOR
IN TASK 3 PART 2(B)
Epochs Precision Recall F1-Score
2 50 100 67
4 45 100 62
6 30 95 45
8 25 100 40
F1-Scores of these reading also indicate that higher epochs
generally led to better results. Similarly, on Task 3, while 2
epochs reported a precision of 100%, the recall was much
lower (79%), therefore motivating us to experiment further.
High accuracy on this task is no surprise since it measures
model performance after training and testing on the non-
prostate tissues.
V. CONCLUSION
We presented a deep generative learning model DeepCancer
for detection and classification of inflammatory breast cancer
and prostate cancer samples. The features are learned through
an adversarial feature learning process and then sent as input
to a conventional classifier specific to the objective of interest.
After modifications through specified hyperparameters, the
model performs quite comparatively well on the task tested
on two different datasets.
The proposed model utilized cDNA microarray gene ex-
pressions to gauge its efficacy. Based on deep generative
learning, the tuned discriminator and generator models, D and
Fig. 6. Effects of different configurations of the model on the Average Precision, Recall and F1-scores
Fig. 7. Evaluation of the convolutional GAN based on varying GAN-sensitive hyperparameters
G respectively, learned to differentiate between the gene sig-
natures without any intermediate manual feature handpicking,
indicating that much bigger datasets can be experimented on
the proposed model more seamlessly. The DeepCloud model
will be a vital aid to the medical imaging community and,
ultimately, reduce inflammatory breast cancer and prostate
cancer mortality.
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